Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial. - Wikidata - awgldk - TriplyDB

Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial.

Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial.

http://www.wikidata.org/entity/Q35467228

about

Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms Alcoholic liver disease: the gut microbiome and liver cross talk Implication of the intestinal microbiome in complications of cirrhosis Gut microbiota: its role in hepatic encephalopathy Evaluation of the impact of rehospitalization in the management of hepatic encephalopathy Management of Hepatic Encephalopathy: A Primer Emerging concepts in alcoholic hepatitis Gut Microbiota and Complications of Liver Disease.The Gut Microbiota: The Gateway to Improved Metabolism.Gut microbiome, gut function, and probiotics: Implications for health.Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus Production Conditions Affect the In Vitro Anti-Tumoral Effects of a High Concentration Multi-Strain Probiotic Preparation.Immune-to-Brain Communication Pathways in Inflammation-Associated Sickness and Depression.Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota.Covert and Overt Hepatic Encephalopathy: Diagnosis and Management Nutritional modulation of gut microbiota - the impact on metabolic disease pathophysiology Reversal of Low-Grade Cerebral Edema After Lactulose/Rifaximin Therapy in Patients with Cirrhosis and Minimal Hepatic Encephalopathy Effects of a Multispecies Probiotic Mixture on Glycemic Control and Inflammatory Status in Women with Gestational Diabetes: A Randomized Controlled Clinical Trial Probiotic mixture VSL#3 reduce high fat diet induced vascular inflammation and atherosclerosis in ApoE(-/-) mice.Fermented milk containing Lactobacillus paracasei subsp. paracasei CNCM I-1518 reduces bacterial translocation in rats treated with carbon tetrachloride.Fecal Microbiota Transplant from a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial.Probiotics in management of hepatic encephalopathy.Progress in Our Understanding of the Gut Microbiome: Implications for the Clinician.Probiotics for people with hepatic encephalopathy.Neuroinflammation in liver disease: sessional talks from ISHEN.The gut microbiome and liver cancer: mechanisms and clinical translation.Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota.Impact of Hepatic and Extrahepatic Insults on the Outcome of Acute-on-Chronic Liver Failure.Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis.HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients.Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step.The Relationship Between the Gut Microbiota and Liver Disease Gut Microbiota and Metagenomic Advancement in Digestive Disease Recent advances in hepatic encephalopathy.Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials.Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy.The Pharmabiotic Approach to Treat Hyperammonemia.Is it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy?Factors contributing to the development of overt encephalopathy in liver cirrhosis patients.

P2860

Q26744689-9535FC1E-5449-4698-B966-51A36A45E325 Q26770137-9D358F32-A271-4D8F-9B30-BFF30E0AE4C3 Q27025627-28620601-57CE-4D26-815F-DA05FC74D2C6 Q28068832-A61EFC3E-9297-4842-AB39-098C85229DA6 Q28084576-E08CDD0D-1066-447C-91C5-6D02B1C49ACD Q28085014-1173121A-74C6-46A8-98D6-A8CA9E406F98 Q28275197-2B82F80D-D9A1-40F9-9232-426AFEA78069 Q30234425-58255598-4E35-4D91-8B8B-5F36C77E4D35 Q30236024-A6239EF4-6B1E-4820-AB92-DB68272EAB53 Q30241392-20F885FE-3FF3-4837-9059-F95C3CBC0265 Q35616074-C8E1822B-1639-454D-AF4A-0193B8B57B02 Q35875078-9B592FB7-56AA-46CD-B4F1-14A62DEAAAC0 Q36140994-37970473-D100-49F0-84A6-FB05C8B191BB Q36146367-80F4121E-059A-41A4-A8DF-12C49C694893 Q36148926-FC013847-493E-4B2D-A827-CC3DA888EBBA Q36199772-32F0F690-5027-4CD3-9A08-1301834FE25A Q36590565-24D400E7-62EF-461C-AC69-638282D002C2 Q36752000-6EC69841-1295-4D9E-970F-2C4BA1CFBC0A Q37080695-6E50EA3B-06AD-4B36-9349-F0C1C7DBF178 Q37217947-AB9EAD76-72F7-45AB-843F-DA058B7236AB Q37734650-86DFE268-05AC-4000-AC36-6FBA48366153 Q38740977-3CCC6E04-A640-4023-8175-048F5300B115 Q38819352-E4297979-4042-4D35-AED4-4FB902C68C61 Q38905778-BD26EA68-2F85-435B-B5B3-3108AF8671F3 Q38946102-554E0348-7094-4EA3-8986-052F0571198F Q38977487-F7799508-5079-4409-B2AC-8282AB82395B Q39414187-7D8776D2-AEDE-46BA-9BBF-A4B4380BF0E0 Q40087509-946F770F-B664-44B0-A423-430C4730EFD9 Q40271237-B42345E5-8F5F-4EC9-A5A3-E4E75068CFD7 Q40552238-1E5E0DAF-C216-48C4-BAD8-93188B03B26A Q40612995-C172EEBF-77D4-434B-959B-C3388210B839 Q41706834-6ECAA506-CFC3-4E76-9DD5-64950AECF013 Q41896010-9A3290BD-10B3-4AFE-9373-7E951B2A8931 Q42278028-D01FB157-B4FD-48D0-AB09-D2F3B3BB2FBF Q42353683-509320AF-440E-4417-98E9-E10717F3BD23 Q45291275-477B57B5-AD01-4C5C-BEB4-E5F1C6C6E7A1 Q47116789-43941103-AE81-440E-AC41-8A4B7301C922 Q47831420-DD69BD68-17B0-4A6A-97DB-B8302FE8C2DD Q48245085-FA0D6147-8EE9-4632-827E-88E5EDA33DD7 Q48651542-9825D748-7433-412C-A847-A12E2F0C15E6

P2860

Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial.

http://www.wikidata.org/entity/Q35467228

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Probiotic VSL#3 reduces liver ...... randomized, controlled trial.

@ast

Probiotic VSL#3 reduces liver ...... randomized, controlled trial.

@en

type

label

Probiotic VSL#3 reduces liver ...... randomized, controlled trial.

@ast

Probiotic VSL#3 reduces liver ...... randomized, controlled trial.

@en

prefLabel

Probiotic VSL#3 reduces liver ...... randomized, controlled trial.

@ast

Probiotic VSL#3 reduces liver ...... randomized, controlled trial.

@en

P1433

Q35467228-DF47B181-C871-4791-B89E-9EDFAB7B7B86

P1476

Q35467228-01FF56EA-9B90-4309-A5C2-1470764C0D35

P2093

Q35467228-00C935A1-3B4A-4E26-B4B9-4209AB7926A1

Q35467228-29C4A971-4C1D-4037-9F76-8A52AAF98CA3

Q35467228-343C8E98-0D2D-4CE4-ABBE-BA1381CBA93D

Q35467228-69F73C54-3C62-4068-BB6B-7CB6C7805F4D

Q35467228-8E9DFFBB-A3FD-4C5C-A1EC-262479A45BA4

Q35467228-A9DFD1B3-8467-4452-AF69-12C489B219EB

Q35467228-C8C4354E-7C75-434C-97B8-2FC6F099C0BD

Q35467228-CAE3FEC0-B7BC-4EAD-AFE0-6714ECA3005D

Q35467228-DE03F5B8-4287-4A27-8A11-2206DAB8F416

Q35467228-FFD132BF-FD39-47D5-8FDF-AE54C2385B50

P304

Q35467228-1989A4C0-1045-4EDB-82F3-32D1C59737A7

P31

Q35467228-B0794699-F004-4DF0-BEBC-A25066006C73

P356

Q35467228-0EC7CF6A-34E6-4DA4-A935-4CA22218518D

P407

Q35467228-BF7A2FEC-3D71-46BE-AA70-0C6A5F2A3A1B

P433

Q35467228-BA8317D7-BFD3-4E44-B125-46591D5F9523

P478

Q35467228-10464669-3324-4730-B042-EA65AB300C33

P577

Q35467228-A3DF7B51-4E03-4CEA-8F04-0B36E6B2E5D6

P698

Q35467228-81D9F60B-6779-4B02-AA26-555DD9ADDFAB

P921

Q35467228-CE6A46EE-5228-4032-9FB1-6533D3FAD586

Q35467228-D079282D-E287-4E11-B493-0712583936BC

Q35467228-F0A55249-B633-4A1D-A679-400AECB4C636

P356

J.GASTRO.2014.08.031

P1433

Gastroenterology

P1476

Probiotic VSL#3 reduces liver ...... randomized, controlled trial.

@en

P2093

Ajay Duseja

http://www.w3.org/2001/XMLSchema#string

Amit Khattri

http://www.w3.org/2001/XMLSchema#string

Ashish Garg

http://www.w3.org/2001/XMLSchema#string

Baldev Rana

http://www.w3.org/2001/XMLSchema#string

Kiran K Thumburu

http://www.w3.org/2001/XMLSchema#string

Madhu Chopra

http://www.w3.org/2001/XMLSchema#string

Radha K Dhiman

http://www.w3.org/2001/XMLSchema#string

Samir Malhotra

http://www.w3.org/2001/XMLSchema#string

Swastik Agrawal

http://www.w3.org/2001/XMLSchema#string

Yogesh K Chawla

http://www.w3.org/2001/XMLSchema#string

P304

1327-37.e3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2014.08.031

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

147

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25450083

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis

hospitalization